Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06380049

Predicting Fall Risk in Stroke Patients Using a Machine Learning Model and Multi-Sensor Data

The study assesses a machine learning model developed to predict fall risk among stroke patients using multi-sensor signals. This prospective, multicenter, open-label, sponsor-initiated confirmatory trial aims to validate the safety and efficacy of the model which utilizes electromyography (EMG) signals to categorize patients into high-risk or low-risk fall categories. The innovative approach hopes to offer a predictive tool that enhances preventative strategies in clinical settings, potentially reducing fall-related injuries in stroke survivors.

Recruiting

Interested in participating?

Request Info

Key information

Age range

19 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Seoul National University Hospital

Seoul, Jongno, 03080, South Korea

Location status: Recruiting

Location contact

junghyun kim, Ph. D.

CONTACT

82+1021740890

About this study

Objective: The primary objective is to develop and validate a machine learning-based model that uses multi-sensor (EMG) signals to identify stroke patients at high risk of falls. This model aims to improve on traditional fall risk assessments which rely heavily on physical assessments and patient history.

Study Design: This is a prospective, multicenter, open-label, confirmatory clinical trial. It involves collecting EMG data from stroke patients and applying machine learning techniques to predict fall risk. The study will compare the predictive accuracy of the machine learning model against conventional fall risk assessment tools.

Methods:

  • Participants:
  • Sample Size: 80 stroke patients and 10 healthy adults to establish baseline EMG readings.
  • Interventions:
  • Participants will undergo EMG signal collection from key lower limb muscles while performing standardized movements.
  • Outcome Measures:
  • Primary Outcome: Sensitivity and specificity of the machine learning model in predicting high-risk fall patients.
  • Secondary Outcomes: Comparison of the machine learning model's predictive performance with traditional fall risk assessment tools (e.g., Berg Balance Scale).

Data Collection:

  • EMG sensors will be attached to the patients' muscles of the lower limbs. Sensors will record muscle activity during movement, which will then be analyzed using the machine learning model.
  • The predictive model will be trained using features extracted from the EMG signals, and its performance will be validated against actual fall incidents reported during the follow-up period.

Statistical Analysis:

  • The machine learning model's efficacy will be measured through its sensitivity (ability to correctly identify high-risk patients) and specificity (ability to correctly identify low-risk patients).
  • Receiver Operating Characteristic (ROC) curves and Area Under the Curve (AUC) statistics will be used to assess model performance.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Stroke Participants

Inclusion criteria

  • 19 years and older
  • the onset of the stroke is less than 3months ago
  • Lower extremity weakness due to stroke (MMT =< 4 grade)
  • Cognitive ability to follow commands

Exclusion criteria

  • stroke recurrence
  • other neurological abnormalities (e.g. parkinson's disease).
  • severely impaired cognition
  • serious and complex medical conditions(e.g. active cancer)
  • cardiac pacemaker or other implanted electronic system

Health Participants

Inclusion criteria

  • 19 years and older
  • Individuals who fully understand the necessity of the study and have voluntarily consented to participate as subjects

Exclusion criteria

  • other neurological abnormalities (e.g. parkinson's disease).
  • severely impaired cognition
  • serious and complex medical conditions(e.g. active cancer)
  • cardiac pacemaker or other implanted electronic system

Treatment and study plan

EMG Analysis Software

Device

Surface electromyography devices are non-invasive tools that measure electrical activity produced by skeletal muscles through sensors placed on the skin.

Primary outcomes

  1. Sensitivity of the Machine Learning Model

    Time frame: At the time of the single visit

    The primary outcome measure is the sensitivity of the machine learning model, which refers to its ability to correctly identify patients who are at high risk of falls. Sensitivity is defined as the proportion of actual positives that are correctly identified.

Secondary outcomes

  1. Specificity of the Machine Learning Model

    Time frame: At the time of the single visit

    Specificity measures the proportion of actual negatives that are correctly identified.

Other outcomes

  1. Area Under the Receiver Operating Characteristic Curve

    Time frame: At the time of the single visit

    This is a performance measurement for classification problems at various threshold settings. ROC is a probability curve, and AUC represents the degree or measure of separability. It tells how much the model is capable of distinguishing between classes.

  2. Matthews Correlation Coefficient

    Time frame: At the time of the single visit

    The MCC is used in machine learning as a measure of the quality of binary classifications. It takes into account true and false positives and negatives and is generally regarded as a balanced measure which can be used even if the classes are of very different sizes.

Study contacts

Contact information is provided by the study sponsor or research team.

JungHyun Kim, prof

CONTACT

[email protected]

82+1088632341

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Collaborators

  • Ministry of Trade, Industry & Energy, Republic of Korea

Registry information

Official study title

Development and Validation of a Machine Learning-based Model to Predict a High-risk Group for Falls Using Multi-sensor Signals in Stroke Patients

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
Apr 23, 2024
Registry last updated
Jun 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.